Actuate Therapeutics
$2.74
1
+$0.45+19.65% Tuesday 20:00
Statistics
Day High
2.74
Day Low
2.24
52W High
11.99
52W Low
2.05
Volume
112,949
Avg. Volume
72,651
Mkt Cap
63.69M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.24755
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-54.57MNet Income
Analyst Ratings
$20.00Average Price Target
The highest estimate is 20.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ACTU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.
Show more...
CEO
Mr. Daniel M. Schmitt
Employees
10
Country
US
ISIN
US0050831009
Listings
0 Comments
Share your thoughts
FAQ
What is Actuate Therapeutics stock price today?▼
The current price of ACTU is $2.74 USD — it has increased by +19.65% in the past 24 hours. Watch Actuate Therapeutics stock price performance more closely on the chart.
What is Actuate Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Actuate Therapeutics stocks are traded under the ticker ACTU.
Is Actuate Therapeutics stock price growing?▼
ACTU stock has risen by +18.1% compared to the previous week, the month change is a -26.74% fall, over the last year Actuate Therapeutics has showed a -59.1% decrease.
What is Actuate Therapeutics market cap?▼
Today Actuate Therapeutics has the market capitalization of 63.69M
When is the next Actuate Therapeutics earnings date?▼
Actuate Therapeutics is going to release the next earnings report on June 03, 2026.
What were Actuate Therapeutics earnings last quarter?▼
ACTU earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.24 USD resulting in a -0.85% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Actuate Therapeutics revenue for the last year?▼
Actuate Therapeutics revenue for the last year amounts to 0 USD.
What is Actuate Therapeutics net income for the last year?▼
ACTU net income for the last year is -54.57M USD.
How many employees does Actuate Therapeutics have?▼
As of April 01, 2026, the company has 10 employees.
In which sector is Actuate Therapeutics located?▼
Actuate Therapeutics operates in the Health Care sector.
When did Actuate Therapeutics complete a stock split?▼
The last stock split for Actuate Therapeutics was on August 15, 2000 with a ratio of 2:1.
Where is Actuate Therapeutics headquartered?▼
Actuate Therapeutics is headquartered in Fort Worth, US.